Talk:Anti-Müllerian hormone

Untitled
The section on ovarian reserve and AMH needs clarification. AMH is produced by primary follicles on up to the very early antral stage, i.e., just before cyclic recruitment, hence serum levels do not vary over a woman's menstrual cycle. Thus high levels can occur in PCOS and low levels in poor ovarian reserve. An antral follicle count (AFC) by ultrasound is unlikely to reveal much additional information as AFC correlates well with AMH. A high AMH level does not neccessarily mean better fertility as it may indicate PCOS or possibly ovarian cancer. In fact AMH may drop before antral follicle counts do showing that low AMH serum levels is an earlier marker of declining ovarian reserve than AFC.

Currently, AMH has been shown to be a circulating marker specifically for granulosa cell tumour (GCT). GCT constitutes 3% of all ovarian tumours. According to one study AMH is increased only in the serum from women with GCT.

See:

La Marca and Volpe, 2007, "The Anti-Mullerian hormone and ovarian cancer." Human Reproduction Upate 13(3):265-73. PubMed Index: 17213257.

Das M, DJ Gillott, E Saridogan and O Djahanbakhch, 2008. "Anti-Mullerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome." Human Reproduction. PubMed Index: 18550512. June 10, 2008 Epub ahead of print.

Wiki Education Foundation-supported course assignment
This article is or was the subject of a Wiki Education Foundation-supported course assignment. Further details are available on the course page. Student editor(s): AlexandriaLee.

Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 14:26, 16 January 2022 (UTC)

Addressing sections that need additions above
Hi, I am new to the page, as well as to Wikipedia editing. From the introduction above on certain sections, I'd like to try and work on expanding on the topic of AMH on ovarian reserve. I have found some papers to address the overall background of the protein and its role in selection and recruitment. I've cited them here. .And I'd also like to discuss a bit about AMH and its role in both PCOS and normal type women. If there is anything else that needs addressing, or if there is any guidance or corrections that you'd like to share, I am all ears. Thank you very much!AlexandriaLee (talk) 18:32, 4 May 2017 (UTC)

Predicting menopause

 * http://news.bbc.co.uk/today/hi/today/newsid_8767000/8767137.stm
 * http://www.google.com/hostednews/ap/article/ALeqM5hOwp2d720QM5kPdpmAurC9_B1zTQD9GJQL0O0

Measurement - JCEM review
10.1210/jc.2013-3476 JFW &#124; T@lk  12:43, 7 March 2014 (UTC)

Contraception and AMH
https://journals.lww.com/menopausejournal/Abstract/2022/02000/Association_of_oral_contraceptives_and_tubal.16.aspx

February 2022

"Oral contraceptives (OCs) are commonly used methods of contraception that may impact ovarian function. Few studies have examined the association of these factors with antimüllerian hormone (AMH), a marker of ovarian aging.

We observed a significant, inverse association between duration of OC use and mean AMH levels (P for trend = 0.036)".

https://www.empr.com/home/news/oral-contraceptive-use-tied-to-marker-of-ovarian-function/

https://www.empr.com/tag/contraception/

---

What about other hormonal contraceptives?

And other contraceptives, like https://en.wikipedia.org/wiki/Copper_IUDs?

--91.159.188.74 (talk) 08:50, 18 February 2022 (UTC)

Wiki education activity- evaluate an article
The article's tone is neutral. Source links work and are relevant to the subject.

- Pisawagner (talk) 17:46, 20 January 2024 (UTC)